Clinical utility of NT-proBNP levels in late heart transplantation patients

被引:8
作者
Avello, Noelia [1 ]
Prieto, Belen [1 ]
Molina, Beatriz D. [2 ]
Rodriguez-Lambert, Jose L. [2 ]
Alvarez, Francisco V. [1 ,3 ]
机构
[1] Hosp Univ Cent Asturias, Serv Bioquim Clin, Oviedo 33006, Spain
[2] Hosp Univ Cent Asturias, Serv Cardiol, Oviedo 33006, Spain
[3] Univ Oviedo, Dept Bioquim & Biol Mol, Oviedo, Spain
关键词
Heart transplantation; Natriuretic peptides; Rejection; Prognosis; BRAIN NATRIURETIC PEPTIDE; CARDIAC ALLOGRAFT-REJECTION; INTERNATIONAL-SOCIETY; LUNG-TRANSPLANTATION; BNP; DIAGNOSIS; FAILURE; MORTALITY; VASCULOPATHY; SURVIVAL;
D O I
10.1016/j.cca.2009.10.021
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The present work was aimed to describe NT-proBNP levels in heart transplant patients after the first year postsurgery. Methods: NT-proBNP concentration was measured in 1231 samples from 142 patients when a routine four-month follow-up was carried out, including other biochemical and clinical examinations. Endomyocardial biopsies were performed only upon clinical suspicion of acute rejection. Results: NT-proBNP concentrations were not significantly correlated to post-transplantation time, though differences were observed according to clinical symptoms (Kruskal-Wallis test, p<0.001). Although multivariate analysis revealed statistically significant association between NT-proBNP concentration and some qualitative (cardiac allograft vasculopathy-CAV-, sex, diabetes) and quantitative (creatinine, hematocrit, age) variables, only moderately relevant contribution was observed for creatinine and CAV. Patients with rejection showed noticeable increases in serum NT-proBNP concentrations. above more than 2.5 times the reference change value (97%). NT-proBNP concentrations higher than 1000 ng/L increased in 3.5 times (95%CI: 2.4-5) the risk of death in less than one year. Conclusions: After the first year from surgery, NT-proBNP concentrations were not associated to post-transplantation time and NT-proBNP could be a useful diagnostic marker for rejection, whenever serial measurements are made. A NT-proBNP cutoff value of 1000 ng/L was identified for classifying patients at risk of death after one year. (c) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:161 / 166
页数:6
相关论文
共 30 条
[1]   Usefulness of N-terminal-pro-brain natriuretic peptide levels in predicting survival in heart transplant recipients [J].
Ambrosi, P ;
Oddoze, C ;
Ribéri, A ;
Arques, S ;
Portugal, H ;
Métras, D ;
Habib, G .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (12) :1585-1587
[2]   Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement - Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study [J].
Anwaruddin, S ;
Lloyd-Jones, DM ;
Baggish, A ;
Chen, A ;
Krauser, D ;
Tung, R ;
Chae, C ;
Januzzi, JL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (01) :91-97
[3]   Cardiac transplant vasculopathy [J].
Aranda, JM ;
Hill, J .
CHEST, 2000, 118 (06) :1792-1800
[4]   Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection [J].
Arnau-Vives, MA ;
Almenar, L ;
Hervas, I ;
Osa, A ;
Martinez-Doiz, L ;
Rueda, J ;
Zorio, E ;
De Urbina, LMO ;
Perez, JL ;
Mateo, A ;
Palencia, M .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (07) :850-856
[5]   Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation [J].
Arora, Satish ;
Gullestad, Lars ;
Wergeland, Ragnhild ;
Simonsen, Svein ;
Holm, Torbjorn ;
Hognestad, Aina ;
Ueland, Thor ;
Geiran, Odd ;
Andreassen, Arne .
TRANSPLANTATION, 2007, 83 (10) :1308-1315
[6]   VENTRICULAR EXPRESSION OF BRAIN NATRIURETIC PEPTIDE GENE FOLLOWING ORTHOTOPIC CARDIAC TRANSPLANTATION IN CHILDREN - A 3 YEAR FOLLOW-UP [J].
ATIONU, A ;
SORENSEN, K ;
WHITEHEAD, B ;
SINGER, D ;
BURCH, M ;
CARTER, ND .
CARDIOVASCULAR RESEARCH, 1993, 27 (12) :2135-2139
[7]   N-terminal pro-Brain natriuretic peptide as a potential non-invasive marker of cardiac transplantation rejection [J].
Avello, N. ;
Molina, B. D. ;
Llorente, E. ;
Bernardo, M. J. ;
Prieto, B. ;
Alvarez, F. V. .
ANNALS OF CLINICAL BIOCHEMISTRY, 2007, 44 :182-188
[8]  
Billingham M E, 1990, J Heart Transplant, V9, P587
[9]   High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure [J].
Bruins, S ;
Fokkema, MR ;
Römer, JWP ;
DeJongste, MJL ;
Van der Dijs, FPL ;
Van den Ouewland, JMW ;
Muskiet, FAJ .
CLINICAL CHEMISTRY, 2004, 50 (11) :2052-2058
[10]   Value of NT-proBNP determinations in the follow-up of heart transplantation [J].
Cuppoletti, A ;
Roig, E ;
Pérez-Villa, F ;
Marin, JL ;
Orús, J ;
Vallejos, I ;
Rivera, A ;
Botta, C .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) :4033-4035